Terminal Sterilization Services Market Analysis, Key Factors, Size, Share, Drivers Report 2024 To 2033

The terminal sterilization services market size has grown rapidly in recent years. It will grow from $11.62 billion in 2023 to $12.9 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to increasing stringency of regulatory standards, rise in healthcare expenditure, growing demand for sterile medical devices, increasing number of surgical procedures, globalization of pharmaceutical manufacturing.

The terminal sterilization services market size is expected to see rapid growth in the next few years. It will grow to $20.23 billion in 2028 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rapid expansion of biopharmaceutical industry, demand for sterilization of single-use medical devices, focus on outsourcing sterilization processes, rise in contract sterilization services, globalization of medical device manufacturing, increased adoption of sterile packaging. Major trends in the forecast period include rising outsourcing trends, advancements in sterilization technologies, focus on single-use devices, stringent regulatory compliance, focus on environmental sustainability.

Market Overview -
Terminal sterilization is the process of sterilizing a product in its final stage by exposing it to either physical or chemical sterilizing agents. Terminal sterilization services primarily ensure the sterility of the product and also obtain a sterility assurance level (SAL) for that product.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=10068&type=smp

Rising Hospital-Acquired Infections Propel Growth In Terminal Sterilization Services Market
The increasing incidence of hospital-acquired infections is expected to propel the growth of the terminal sterilization services market going forward. Healthcare-associated infections, also known as hospital-acquired infections, are nosocomially acquired infections that are neither present nor incubating at the time of hospital admission. Terminal sterilization is a mandatory process in hospitals for medical devices and instruments, especially those that are inserted into the patient's body after every use, to avoid contamination and protect the patients from hospital-acquired infections. For instance, in May 2022, according to reports by the World Health Organization, a Switzerland-based health agency, more than 24% of patients worldwide were affected by healthcare-associated infections in 2022. Furthermore, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, in the US, there were estimates that hospital-acquired infections accounted for an estimated 1.7 million infections and 99,000 associated deaths each year, and additionally, 32% of all healthcare-acquired infections in the US by 2022. These numbers are expected to rise in the future. Therefore, the increasing incidence of hospital-acquired infections drives the market for terminal sterilization services.

Competitive Landscape -
Major companies operating in the terminal sterilization services market report are Steris plc, Getinge Group, Advanced Sterilization Products Services Inc., 3M Company, Belimed AG, Sterigenics International LLC, TSO3 Inc., Olympus Corporation, Matachana Group, Andersen Sterilizers Inc., Steelco S.P.A, Fedegari Group, Sotera Health Co., E-BEAM Services Inc., BGS Beta-Gamma-Service GmbH & Co. KG, Stryker Corporation, Medistri SA, Noxilizer Inc., H.W.Andersen Products Ltd., Cosmed Group, Cretex Companies Inc., Life Science Outsourcing Inc., MICROTROL Sterilisation Services Pvt. Ltd., Avantti Medi Clear, Steripure SAS, Europlaz Technologies Limited, Centerpiece Holdings LLC, Midwest Sterilization Corporation, Blue Line Sterilization Services LLC, Johnson And Johnson

Next-Generation Vhp In Response To The Need For Advanced Solutions
Major companies operating in the terminal sterilization services market are focused on developing next-generation VHP such as VHP Biodecontamination Systems in response to the need for advanced solutions. Vaporized Hydrogen Peroxide (VHP) bio-decontamination systems are advanced technologies designed to achieve a significant reduction in bioburden. For instance, in September 2021, Steris, a US-based provider of products and services that support patient care, launched VHP 100i and 1000i vaporized hydrogen peroxide biodecontamination systems, designed for a 6-log reduction in bioburden in pharmaceutical, medical device, and research settings. These systems can be seamlessly integrated into building automation and HVAC systems, enabling convenient and frequent decontamination of various environments. In contrast to fogging systems, Steris VHP offers a dry, small-molecule process that is compatible with diverse surface materials, including sensitive electronic equipment.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/terminal-sterilization-services-global-market-report

Key Segments -

The terminal sterilization services market covered in this report is segmented -

1) By Type: Contract Sterilization Services, Sterilization Validation Services
2) By Method: Ethylene Oxide (Eto) Sterilization, Gamma Sterilization, Steam Sterilization, Electron Beam Radiation Sterilization, X-Ray
3) By Technology: Gravity, Vacuum, Steam, Forced Convention, Natural Convention
4) By End-Use: Hospital And Clinics, Pharma And Nutraceuticals, Medical Device Manufacturing/Packaging, Academic Research Institutes, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.